| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |